Sopharma registered 35% YoY decline in Jun’24 unconsolidated sales, including 7% YoY decrease in domestic sales, and 49% YoY drop in exports. 6-mo 2024 sales were down by 8% YoY due to 15% YoY decrease of exports, despite 4% increase of domestic sales.